Panel Discussion: Neuropsychiatry at a Crossroads: Where Science, Strategy & Deal Making Converge
- What indications are you excited about and actively exploring?
- Which drug modalities are you excited about and actively exploring?
- In 2026 are we ready for precision psychiatry, and what might we need to improve in terms of diagnostics to get there (genetics, etc.)?